- Market Capitalization, $K 339,961
- Shares Outstanding, K 18,710
- Annual Sales, $ 21,350 K
- Annual Income, $ -5,610 K
- 60-Month Beta 1.04
- Price/Sales 11.15
- Price/Cash Flow N/A
- Price/Book 5.69
|Period||Period Low||Period High||Performance|
| || |
+4.79 (+35.80%)since 01/14/20
| || |
+7.06 (+63.55%)since 11/14/19
| || |
+13.77 (+312.95%)since 02/14/19
Zacks.com featured highlights include: AQN, IDN, FLGT and SMED
Picking breakout stocks is one of the most favored methods for those utilizing an active investing approach since this strategy offers the scope of superlative returns.
Is (FLGT) Outperforming Other Medical Stocks This Year?
ANP Technologies Inc. (ANP) and Fulgent Pharma LLC through their partner Moffitt Cancer Center have successfully licensed the rights to develop a novel targeted therapy in the area of leukemia to Celgene...
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
U.S. stocks rallied to attained fresh all-time highs in 2019, as the momentum continued in 2020. Here are five stocks that are poised to grow.
The Zacks Analyst Blog Highlights: Fulgent Genetics, Teekay Tankers, Ultra Clean, Boot Barn and Sonic Automotive
Buy these five bets that reap solid returns from the Wall Street's rally in 2019 and are poised to yield high in the coming year.
Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced that its Chairman...
Zacks.com featured highlights include: Brinker International, Sonic Automotive, Fulgent Genetics, Hewlett Packard and Regeneron Pharmaceuticals